Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertensionMark Toshner, Paul A. Corris, Gerry Coghlan et al.|European Respiratory Journal|2021Cited by 89
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical OutcomeChristopher J. Rhodes, Martin R. Wilkins, P. Morales Otero et al.|American Journal of Respiratory and Critical Care Medicine|2020Cited by 73
Defining the clinical validity of genes reported to cause pulmonary arterial hypertensionCarrie L. Welch, David Langleben, Micheala A. Aldred et al.|Genetics in Medicine|2023Cited by 73
Mendelian randomisation analysis of red cell distribution width in pulmonary arterial hypertensionAnna Ulrich, Christopher J. Rhodes, John Wharton et al.|European Respiratory Journal|2019Cited by 42
NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease ClassificationWilliam M. Oldham, Lei Xiao, Anna R. Hemnes et al.|Journal of the American College of Cardiology|2021Cited by 20